These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 7408677)

  • 1. [Significance of computer tomography in diagnosis of bone metastases].
    Löer F; Stenbock-Femor N Graf
    Dtsch Med Wochenschr; 1980 Jun; 105(26):937-8. PubMed ID: 7408677
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for bone metastases.
    Peh WC
    Am J Orthop (Belle Mead NJ); 2000 May; 29(5):405. PubMed ID: 10868444
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of bone metastases.
    Galasko CS
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1873-5. PubMed ID: 7330641
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of skeletal metastases and assessment of response to treatment.
    Galasko CS
    Clin Orthop Relat Res; 1995 Mar; (312):64-75. PubMed ID: 7634619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary bone cancer. Etiology, diagnosis, treatment principles].
    Kaplan G
    Rev Prat; 1989 Dec; 39(28):2553-8. PubMed ID: 2602885
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is your diagnosis? Subperiosteal cortical metastases of a non-small-cell bronchial carcinoma (adenocarcinoma) of the right tibia, e.g. "cookie bite lesion"].
    Wiesner W; Hauser M
    Praxis (Bern 1994); 2000 Jul; 89(27-28):1133-6. PubMed ID: 10959200
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superficial bone metastases: report of two cases from colonic origin].
    Girodeau A; Ait Ameur A; Boyer B; Ciribilli J; Ehre P; Danguy Des Deserts M
    J Radiol; 2000 Sep; 81(9):982-6. PubMed ID: 10992098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone tumors. American College of Radiology. ACR Appropriateness Criteria.
    Berquist TH; Dalinka MK; Alazraki N; Daffner RH; DeSmet AA; el-Khoury GY; Goergen TG; Keats TE; Manaster BJ; Newberg A; Pavlov H; Haralson RH; McCabe JB; Sartoris D
    Radiology; 2000 Jun; 215 Suppl():261-4. PubMed ID: 11037436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral glioblastomas and systemic metastases].
    Denier C; Carpentier AF; Mokhtari K; Delattre JY
    Rev Neurol (Paris); 2001 Dec; 157(12):1531-4. PubMed ID: 11924450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
    J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
    Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
    Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L; Salvatore M; Del Vecchio S
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.